SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Fluidigm Corporation (NASDAQ:FLDM) today announced that President and Chief Executive Officer Gajus Worthington will participate in the 23rd Annual Piper Jaffray Healthcare Conference on Wednesday, November 30, 2011, at the New York Palace Hotel, New York City, beginning at 3:00 p.m. Eastern Time.
Mr. Worthington will provide brief remarks and then the session will transition to a question-and-answer period with the audience, moderated by a Piper Jaffray research analyst.
Audio of the Fluidigm presentation will be simultaneously webcast at: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=FLDM&item_id=4229194.
The webcast will be archived for 90 days following the live presentation at http://investors.fluidigm.com/events.cfm.
Fluidigm (NASDAQ: FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits, or chips, and reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets three microfluidic systems including nine different commercial chips to leading pharmaceutical and biotechnology companies, academic institutions and Ag-Bio companies.
For more information, please visit www.fluidigm.com.
“Fluidigm” and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.
Howard High, 650-266-6081
KEYWORDS: United States North America California New York
INDUSTRY KEYWORDS: Health Biotechnology Natural Resources Agriculture Research Science General Health